No definition available.
Malignant neoplasm of thymus, excluding all cancers (controls excluding all cancers)
C3_THYMUS_EXALLC
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
141 |
4. Check minimum number of eventsNone |
141 |
5. Include endpointsNone |
141 |
6. Filter based on genotype QC (FinnGen only) |
141 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of thymus, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
- Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 141 | 64 | 77 |
| Unadjusted period prevalence (%) | 0.03 | 0.02 | 0.03 |
| Median age at first event (years) | 62.20 | 61.56 | 62.73 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 99
- Matched controls
- 989
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D38.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Mediastinum
+∞
52.9
46
*
C37
ICD-10 Finland
Malignant neoplasm of thymus
+∞
46.6
41
*
GEC24
NOMESCO Finland
Thoracoscopic thymectomy
+∞
45.3
40
*
D38.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Thymus
+∞
44.1
39
*
D15.0
ICD-10 Finland
Benign neoplasm: Thymus
+∞
32.0
29
*
8580/3-C37.9
ICD-O-3
Thymoma, NOS, of thymus
+∞
32.0
29
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
41.8
31.5
39
15
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
19.7
28.1
45
40
130
Kela drug reimbursment
Malignant tumour
+∞
26.2
24
*
H02AB02
ATC
dexamethasone; systemic
76.9
25.6
28
5
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
21.6
20
*
GEC23
NOMESCO Finland
Transsternal thymectomy
+∞
20.5
19
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
19.4
18
*
8582/3-C37.9
ICD-O-3
Thymoma, type AB of thymus
+∞
19.4
18
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
7.5
18.7
74
281
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
18.3
17
*
GD1AD
NOMESCO Finland
Thorax CT examination
23.4
17.6
25
14
JN4BD
NOMESCO Finland
Extensive body CT
17.2
17.5
28
22
ZXC96
NOMESCO Finland
Robot assisted procedure
202.8
17.1
17
*
XX3DW
NOMESCO Finland
Time consuming IT work
21.3
15.2
22
13
WX408
NOMESCO Finland
General anesthesy, balanced
6.1
15.0
53
158
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
15.0
14
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
15.0
14
*
WF002
NOMESCO Finland
Radical radiotherapy
174.7
14.9
15
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
174.7
14.9
15
*
A03FA01
ATC
metoclopramide; systemic, rectal
7.8
14.3
36
67
A04AA02
ATC
granisetron; systemic, transdermal
161.2
13.8
14
*
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
47.0
13.6
16
*
B01AB05
ATC
enoxaparin; parenteral
5.7
13.3
47
136
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
6.9
13.0
36
76
GEB30
NOMESCO Finland
Mediastinotomy and excision of lesion
+∞
12.8
12
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
12.8
12
*
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
148.0
12.8
13
*
G70.0
ICD-10 Finland
Myasthenia gravis
148.0
12.8
13
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
11.7
11
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
11.7
11
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
11.7
11
*
A04AA01
ATC
ondansetron; systemic, rectal
29.1
11.5
15
6
WX302
NOMESCO Finland
Thoracal epidural anesthesy
20.9
11.2
16
9
N07AA02
ATC
pyridostigmine; systemic
122.4
10.6
11
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
10.6
10
*
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
+∞
10.6
10
*
Z51.5
ICD-10 Finland
Palliative care
44.9
10.2
12
*
UGC12
NOMESCO Finland
Flexible bronchoscopy
10.9
10.1
19
21
108
Kela drug reimbursment
Myasthenia gravis
110.1
9.6
10
*
L03AA02
ATC
filgrastim; parenteral
110.1
9.6
10
*
R4110
NOMESCO Finland
Physiotherapy
4.3
9.6
43
150
ZX090
NOMESCO Finland
Other technic of radiotherapy
+∞
9.5
9
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
9.5
9
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
9.5
9
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
40.8
9.2
11
*
JN4AD
NOMESCO Finland
Body CT examination
16.4
8.5
13
9
A04AD12
ATC
aprepitant; systemic
+∞
8.4
8
*
N02AA05
ATC
oxycodone; systemic
6.2
8.4
23
46
WZC30
NOMESCO Finland
Teaching
6.2
8.4
23
46
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.7
8.3
45
180
WX402
NOMESCO Finland
General anaesthesia
4.9
8.2
28
73
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
3.8
8.1
41
154
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
7.9
8.0
18
27
JN6AD
NOMESCO Finland
CT of torso and neck
86.3
7.5
8
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
7.4
7
*
8583/3-C37.9
ICD-O-3
Thymoma, type B1 of thymus
+∞
7.4
7
*
116
Kela drug reimbursment
Prostate cancer
+∞
7.4
7
*
8585/3-C37.9
ICD-O-3
Thymoma, type B3 of thymus
+∞
7.4
7
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
7.4
7
*
8581/3-C37.9
ICD-O-3
Thymoma, type A of thymus
+∞
7.4
7
*
TPH04
NOMESCO Finland
Cathetrisation of vein
3.8
6.8
31
106
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
15.7
6.5
10
7
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
19.6
6.4
9
5
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
28.7
6.3
8
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
6.3
6
*
D15.2
ICD-10 Finland
Benign neoplasm: Mediastinum
+∞
6.3
6
*
L01BC06
ATC
capecitabine; oral
+∞
6.3
6
*
8070/3-C37.9
ICD-O-3
Squamous cell carcinoma, NOS, of thymus
+∞
6.3
6
*
C38.1
ICD-10 Finland
Malignant neoplasm: Anterior mediastinum
+∞
6.3
6
*
WW500
NOMESCO Finland
Blood transfusion
16.3
6.0
9
6
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4035726)
58
28
34.49
81.22
1.8
1.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
75
213
6.39
27.30
2.7
1.9
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
87
285
6.36
26.93
3.1
1.9
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
105
425
6.76
25.01
5.1
7.8
inr
1.0
1.3
4.05
22
118
(40758558) Short blood count panel - Blood
76
238
5.76
24.25
14.6
4.4
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
89
325
5.71
23.51
8.5
5.0
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
121
582
8.61
23.00
18.9
6.1
e9/l
3.9
4.2
0.89
109
511
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
34
51
8.47
22.83
3.3
1.8
ug/l
2.1
8.2
0.53
24
39
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
104
451
5.98
21.84
5.3
3.5
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
107
512
5.52
18.88
8.7
5.0
e9/l
0.6
0.6
0.83
94
446
(3006315) Basophils [#/volume] in Blood
107
513
5.50
18.81
8.8
5.0
e9/l
0.0
0.0
0.49
94
450
(3019198) Lymphocytes [#/volume] in Blood
108
523
5.55
18.70
8.9
5.1
e9/l
1.6
1.9
1.04
94
465
(3013115) Eosinophils [#/volume] in Blood
109
532
5.62
18.68
10.2
5.1
e9/l
0.1
0.2
4.72
97
468
(3033658) Prothrombin time (PT) actual/Normal
69
241
4.65
18.27
6.7
2.8
%
89.8
88.5
0.16
69
234
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
102
482
5.04
17.96
12.9
5.3
mmol/l
1.2
1.2
0.07
92
413
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
17
15
12.75
16.52
1.4
1.1
—
—
—
0
0
(3002256) Pathology report gross observation
36
79
5.78
16.51
1.3
1.0
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
81
345
4.17
15.86
3.9
2.7
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
28
50
6.74
15.79
11.7
5.3
mmol/l
25.6
25.4
0.09
28
50
(40768804) Tissue Pathology biopsy report
79
335
4.09
15.47
2.6
1.5
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
18
20
10.17
14.99
2.4
2.8
g/l
4.0
3.6
0.25
18
20
(3023368) Bacteria identified in Blood by Culture
68
265
4.02
14.93
5.6
3.3
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
27
51
6.31
14.36
10.5
9.7
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
27
54
5.95
13.52
20.2
7.3
%
0.6
0.7
0.55
27
54
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
40
115
4.46
13.14
14.6
7.1
kpa
5.4
5.3
0.27
40
109
(3027801) Oxygen [Partial pressure] in Arterial blood
40
115
4.46
13.14
14.6
7.1
kpa
13.6
11.2
1.32
40
110
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
27
56
5.73
12.99
20.0
7.3
%
1.2
1.6
0.82
27
56
(3018418) pH of Serum or Plasma
68
288
3.63
12.80
6.5
2.9
ph
7.4
7.4
—
9
45
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
25
49
5.99
12.75
18.3
7.0
mmol/l
24.9
25.1
0.11
25
44
(3021879) Hepatitis B virus core Ab [Presence] in Serum
27
57
5.62
12.74
1.1
1.5
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
65
271
3.59
12.48
3.6
2.6
e6/l
0.2
0.4
0.96
54
187
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
16
6
29.77
12.35
4.9
1.5
nmol/l
4.7
4.6
—
16
6
(3021589) Normoblasts [#/volume] in Blood
89
455
3.59
12.31
15.4
7.0
e9/l
0.0
0.0
0.49
74
367
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
17
23
8.27
12.12
2.8
1.6
u/ml
0.3
0.4
—
10
13
(3000991) Gas panel - Venous blood
31
80
4.69
11.57
18.6
6.6
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
68
306
3.36
11.34
3.6
2.7
e6/l
75.9
32.6
0.54
57
225
(3015377) Calcium [Moles/volume] in Serum or Plasma
69
314
3.35
11.28
9.8
2.0
mmol/l
2.4
2.4
0.18
64
265
(36304419) Bacteria [Presence] in Urine
62
268
3.34
10.97
3.6
2.4
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
74
357
3.26
10.88
4.0
3.2
e6/l
90.8
56.2
0.24
59
242
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
45
160
3.66
10.82
3.5
2.5
e6/l
5.1
2.6
0.44
31
77
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
36
113
3.94
10.33
2.2
2.5
%
22.8
26.7
0.75
36
102
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
17
28
6.77
10.18
2.2
1.7
%
87.9
90.2
0.13
17
28
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
15
9
18.45
10.12
2.9
1.4
ug/l
26.0
19.3
—
15
9
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
46
173
3.46
10.07
3.5
2.3
e6/l
1.8
1.0
0.55
32
90
(46235355) HIV 1 and 2 tests - Meaningful Use set
42
155
3.43
9.41
1.6
1.7
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
52
221
3.14
9.22
1.8
1.8
mg/l
3.1
3.0
0.06
46
183
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
36
123
3.59
9.05
1.1
1.4
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
40
149
3.35
8.77
2.2
1.8
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
48
200
3.12
8.74
2.1
2.2
e6/l
5.1
4.2
0.17
42
173
(3026782) Osmolality of Urine
45
181
3.18
8.70
2.0
2.4
mosm/kgh2o
576.0
573.1
0.02
39
149
(3003694) ABO and Rh group [Type] in Blood
57
265
2.93
8.52
1.3
1.3
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
50
223
2.92
7.98
2.0
1.7
mg/l
1.3
1.1
0.15
40
168
(3020630) Protein [Mass/volume] in Serum or Plasma
25
72
4.01
7.97
2.4
2.1
g/l
65.6
67.0
0.46
25
66
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
12
19
6.81
7.37
1.1
1.4
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
23
66
3.97
7.35
1.7
1.3
g/l
0.9
1.2
1.44
18
61
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
10
13
8.20
7.21
1.3
1.5
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
30
105
3.36
7.17
1.2
1.5
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
6
0
+∞
6.29
2.3
0.0
u/ml
21.5
—
—
6
0
(4010399)
23
78
3.33
5.73
1.4
1.4
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
133
1121
4.28
5.53
32.4
10.8
mg/l
31.8
23.3
2.30
128
846
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
8
5
16.83
5.47
2.5
1.0
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
13
30
4.67
5.42
3.0
4.3
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34
153
2.61
5.12
1.9
1.5
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
101
729
2.36
5.04
4.3
3.8
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
9
10
9.52
4.86
1.0
1.0
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
18
61
3.24
4.47
1.1
1.2
u/ml
20.7
152.5
2.82
12
56
(3000494) Fungus identified in Specimen by Culture
29
129
2.57
4.44
1.2
1.4
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
43
232
2.23
4.29
3.1
3.6
ng/l
45.7
209.7
1.59
35
186
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
18
63
3.13
4.24
6.0
4.6
ng/l
68.3
92.8
1.18
18
57
(3002385) Erythrocyte distribution width [Ratio]
117
932
2.50
4.18
37.8
12.9
%
14.2
13.6
3.53
117
916
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
17
58
3.20
4.17
1.9
1.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
8
10
8.40
4.12
1.0
2.1
—
—
—
0
0
(3012544) pH of Venous blood
24
101
2.66
4.09
6.1
3.9
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
15
49
3.31
3.94
3.3
2.1
u/l
38.5
42.2
0.32
15
43
(3023520) Reticulocytes [#/volume] in Blood
20
78
2.82
3.92
5.9
2.6
e9/l
55.6
63.6
0.48
15
59
(3019060) Gas panel - Arterial blood
19
75
2.77
3.64
6.7
6.1
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
7
9
8.11
3.60
1.4
1.1
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
23
102
2.50
3.52
1.7
1.6
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
8
15
5.58
3.24
1.9
1.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
8
15
5.58
3.24
1.4
1.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
17
68
2.71
3.18
2.8
1.3
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
12
39
3.27
3.17
3.9
1.8
ug/l
185.2
420.7
0.68
12
34
(3021601) Nitrite [Presence] in Urine by Test strip
73
520
1.84
3.14
4.7
4.4
estimate
0.0
0.0
0.00
13
84
(3037522) Nuclear Ab [Titer] in Serum
27
138
2.18
3.01
1.3
1.4
titre
708.6
614.5
—
7
33
(3009261) Glucose [Presence] in Urine by Test strip
73
527
1.80
2.95
3.4
3.2
estimate
0.0
0.0
0.00
13
82
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
9
22
4.29
2.93
1.0
1.3
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
6
9
6.90
2.89
2.7
4.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
22
105
2.30
2.87
1.9
1.6
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
8
18
4.64
2.84
1.4
1.1
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
135
1227
3.35
2.78
36.8
12.4
umol/l
79.8
78.7
0.14
135
1227
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
7
14
5.20
2.76
1.4
1.6
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
62
433
1.77
2.75
4.4
3.2
ng/l
51.9
45.5
0.09
51
290
(3042631) Mycobacterium sp identified in Specimen
6
10
6.21
2.72
2.8
5.1
—
—
—
0
0
(4268621)
6
10
6.21
2.72
3.3
1.9
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
22
109
2.21
2.64
2.5
2.0
umol/l
8.0
10.4
0.23
22
95
(4062490)
7
15
4.85
2.63
1.3
1.3
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
43
273
1.83
2.60
2.6
3.0
—
—
—
0
0
(3044889) 12 lead EKG panel
101
821
1.81
2.57
4.2
3.7
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
70
514
1.72
2.56
3.4
3.2
estimate
0.0
0.0
0.00
11
85
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
18
83
2.34
2.54
4.6
1.9
ml/min/173m2
82.5
62.8
—
10
29
(3023419) Bacteria identified in Sputum by Culture
7
16
4.54
2.51
1.7
1.7
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
32
187
1.92
2.48
1.3
1.2
iu/ml
14.2
22.6
—
8
58
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
95
765
1.74
2.43
2.9
2.9
u/l
57.2
49.5
0.43
90
720
(44790048)
5
8
6.43
2.39
1.6
1.0
—
—
—
0
0
(44790047)
5
8
6.43
2.39
1.6
1.0
—
—
—
0
0
(44790049)
5
8
6.43
2.39
1.6
1.0
—
—
—
0
0
(44806118)
5
8
6.43
2.39
1.6
1.0
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
106
1196
0.54
2.37
4.2
5.1
mmol/l
2.7
2.8
0.35
101
1109
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
13
53
2.60
2.35
1.5
1.5
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
5
9
5.71
2.23
2.4
1.2
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
5
9
5.71
2.23
1.0
1.0
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
5
9
5.71
2.23
1.2
1.4
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
6
14
4.42
2.17
1.2
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
16
76
2.25
2.12
1.1
1.2
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
49
341
1.67
2.10
3.7
2.1
u/l
63.9
58.2
0.36
49
312
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
5
10
5.14
2.09
1.2
1.4
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
5
10
5.14
2.09
1.0
1.3
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
33
206
1.79
2.08
1.8
1.3
g/l
2.2
2.6
0.53
26
124
(3015736) pH of Urine
56
405
1.63
2.06
3.4
3.1
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
6
15
4.13
2.06
1.0
1.1
pmol/l
189.3
53.9
—
6
15
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
15
4.13
2.06
1.5
1.0
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
105
1177
0.58
2.00
3.8
4.5
mmol/l
4.6
4.7
0.08
99
1094
(3048689) Calprotectin [Mass/mass] in Stool
22
122
1.95
1.98
2.5
1.7
ug/g
136.5
87.7
0.45
22
96
(3035637) Corticotropin [Mass/volume] in Plasma
5
11
4.67
1.96
3.0
1.3
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
5
11
4.67
1.96
1.6
1.2
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
5
11
4.67
1.96
1.6
1.2
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
5
11
4.67
1.96
1.6
1.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
6
16
3.87
1.95
1.3
1.0
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
37
243
1.71
1.95
4.1
3.3
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
6
17
3.64
1.86
1.5
2.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
12
4.28
1.84
1.2
1.0
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
105
1171
0.60
1.82
3.8
4.4
mmol/l
1.4
1.4
0.05
100
1083
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
121
1079
1.86
1.80
29.8
9.7
ml/min/173m2
83.8
80.7
0.89
115
862
(40761511) CBC panel - Blood by Automated count
131
1200
2.29
1.79
23.9
10.2
—
—
—
0
0
(3000492) Spirometry study
21
119
1.90
1.78
1.4
1.3
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
15
75
2.12
1.77
7.2
2.5
e9/l
3.8
3.7
0.10
15
56
(3013290) Carbon dioxide [Partial pressure] in Blood
6
18
3.43
1.76
2.0
2.4
kpa
4.9
5.1
—
6
18
(3027315) Oxygen [Partial pressure] in Blood
6
18
3.43
1.76
2.0
2.4
kpa
8.8
8.1
—
6
18
(3030905) Polymorphonuclear cells [#/volume] in Blood
6
18
3.43
1.76
1.3
2.7
e9/l
4.1
5.2
—
6
18
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
6
18
3.43
1.76
1.3
3.7
%
61.3
60.8
—
6
18
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
11
48
2.40
1.75
4.0
1.1
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
5
13
3.94
1.73
1.6
1.0
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
5
13
3.94
1.73
1.2
1.9
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
5
13
3.94
1.73
1.2
1.2
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
17
91
1.99
1.69
2.6
3.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
8
31
2.67
1.68
1.9
1.5
—
—
—
0
0
(3022313) Gas panel - Capillary blood
11
49
2.35
1.68
5.5
2.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
6
19
3.25
1.68
1.3
2.2
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
16
84
2.02
1.67
2.6
3.0
ng/l
190.9
117.3
0.81
16
76
(3007853) Bacteria identified in Skin by Aerobe culture
20
115
1.86
1.63
1.6
1.7
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
5
14
3.66
1.63
1.6
1.0
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
8
33
2.51
1.56
2.0
1.5
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
5
15
3.41
1.53
1.2
2.0
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
5
15
3.41
1.53
1.2
1.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
5
15
3.41
1.53
1.4
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
5
15
3.41
1.53
1.2
1.2
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
7
27
2.67
1.53
3.1
3.2
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
6
21
2.94
1.52
1.3
1.2
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
6
21
2.94
1.52
1.7
1.3
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
9
37
2.53
1.51
2.1
1.5
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
14
73
2.02
1.50
1.6
1.3
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
9
38
2.46
1.48
4.2
1.1
g/l
34.5
38.5
—
9
32
(40760892) CBC W Ordered Manual Differential panel - Blood
33
228
1.58
1.42
6.8
4.6
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
5
17
3.01
1.37
1.0
1.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
5
17
3.01
1.37
1.0
1.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
9
43
2.17
1.33
1.1
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
25
164
1.64
1.32
1.1
1.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
5
18
2.84
1.29
1.0
1.4
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
5
18
2.84
1.29
1.0
1.3
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
5
18
2.84
1.29
1.0
1.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
5
18
2.84
1.29
1.0
1.0
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
38
278
1.50
1.26
2.1
2.9
—
—
—
0
0
(3020891) Body temperature
8
36
2.29
1.26
17.6
4.1
—
—
—
0
0
(3013512) EKG study
41
305
1.49
1.26
4.2
3.6
—
—
—
0
0
(3035941) MCH [Entitic mass]
135
1283
2.23
1.24
44.5
16.0
pg
30.2
30.4
0.60
135
1259
(3024731) MCV [Entitic volume]
135
1284
2.21
1.24
44.6
16.0
fl
91.3
91.0
0.37
135
1260
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
5
19
2.69
1.22
1.0
1.3
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
103
1127
0.68
1.16
3.4
4.0
mmol/l
1.3
1.3
0.02
98
1035
(3045414) Leukocytes [Presence] in Urine
8
40
2.06
1.14
2.4
1.6
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
26
179
1.55
1.13
1.2
1.3
u/ml
2.4
6.7
—
8
67
(3000963) Hemoglobin [Mass/volume] in Blood
135
1285
2.19
1.11
44.9
16.2
g/l
130.1
138.7
7.42
135
1260
(3048929) Epstein Barr virus Ab [Presence] in Serum
5
21
2.43
1.10
1.0
1.1
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
53
430
1.37
0.99
1.7
1.8
pmol/l
86.7
92.7
0.53
34
203
(1761868) Lipid panel - Serum or Plasma
33
428
0.70
0.98
2.8
2.9
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
7
37
1.94
0.95
1.7
1.4
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
6
28
2.19
0.92
1.0
3.7
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
21
147
1.50
0.86
1.5
1.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
6
31
1.98
0.85
2.0
1.8
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
49
402
1.34
0.84
3.5
3.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
12
74
1.68
0.81
2.1
3.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
113
1049
1.39
0.79
35.2
11.5
%
38.2
41.0
2.79
88
758
(3019230) Fractional oxyhemoglobin in Venous blood
5
23
2.22
0.77
1.0
2.0
%
72.0
60.5
—
5
23
(3029937) Albumin [Presence] in Urine by Test strip
35
277
1.35
0.75
3.9
3.4
estimate
0.0
0.0
—
10
82
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
5
24
2.12
0.75
1.0
1.1
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
14
93
1.56
0.72
5.4
1.7
nmol/l
342.1
377.3
0.41
14
83
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
91
827
1.28
0.69
3.6
3.6
pmol/l
15.2
14.8
0.79
84
749
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
8
50
1.64
0.62
5.8
2.0
%
1.3
1.2
—
8
50
(3019832) Treponema pallidum Ab [Presence] in Serum
11
72
1.57
0.61
2.0
1.5
—
—
—
0
0
(3019225) pH of Specimen
13
90
1.49
0.58
7.5
3.4
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
10
65
1.58
0.57
4.7
2.9
mmol/l
1.2
1.2
—
10
56
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
111
1046
1.29
0.55
4.4
4.3
mu/l
1.9
1.9
0.01
105
956
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
119
1136
1.30
0.49
4.3
4.4
mmol/l
5.8
6.0
1.11
111
1041
(40761535) Cells panel - Urine sediment
12
85
1.45
0.48
6.7
2.8
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
7
50
1.42
0.45
1.0
1.0
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
8
57
1.43
0.43
1.1
1.3
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
9
68
1.35
0.38
3.0
2.0
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
32
369
0.83
0.37
4.2
3.9
mg/mmol
12.9
9.0
0.23
23
233
(3022145) Colonoscopy Study observation
13
100
1.33
0.35
1.3
1.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
6
45
1.35
0.34
3.2
3.0
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
28
240
1.21
0.33
4.4
3.5
kg/l
1.0
1.0
—
5
33
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
14
110
1.30
0.33
2.1
1.8
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
32
362
0.85
0.30
4.5
3.3
%
20.9
24.9
1.39
18
160
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
7
57
1.24
0.29
2.4
3.4
pmol/l
4.0
4.6
—
7
51
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
7
57
1.24
0.29
2.1
2.4
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
5
74
0.66
0.26
1.4
1.4
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
9
77
1.18
0.25
1.6
1.5
—
56.0
—
0
7
(3012516) Albumin [Mass/volume] in Urine
31
345
0.87
0.24
3.5
3.1
mg/l
72.3
257.0
0.48
25
219
(3008898) HLA-B27 [Presence]
5
41
1.23
0.22
1.4
1.1
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.0
—
1.5
—
0
11
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
0
12
0.00
0.21
0.0
2.3
—
35.6
—
0
5
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
11
90
1.24
0.20
2.5
2.7
—
15.7
—
0
5
(1002224) Polysomnography panel
5
69
0.71
0.17
1.0
1.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
12
140
0.84
0.16
1.6
1.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
9
82
1.10
0.15
1.3
1.4
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
9
105
0.85
0.13
1.6
1.7
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
21
225
0.92
0.08
1.1
1.3
u/ml
1.6
1.0
—
6
59
(36660697) Celiac disease serology panel - Serum
7
81
0.86
0.07
1.3
1.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
11
119
0.92
0.04
1.6
1.7
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
13
136
0.95
0.00
16.5
6.9
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
69
692
0.99
0.00
2.8
2.8
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
25
248
1.01
0.00
3.6
2.4
ug/l
0.9
0.7
0.25
19
155
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
10
98
1.02
0.00
2.1
1.6
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
293.7
—
0
7
(3044242) Glucose [Moles/volume] in Arterial blood
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
0
5
0.00
0.00
0.0
2.6
—
1.4
—
0
5
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
5
0.00
0.00
0.0
11.2
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
9
0.00
0.00
0.0
1.1
—
6.4
—
0
9
(3006576) Bicarbonate [Moles/volume] in Blood
0
5
0.00
0.00
0.0
10.2
—
26.2
—
0
5
(3023511) Choriogonadotropin [Units/volume] in Urine
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
86.8
—
0
5
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
106.4
—
0
5
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
6.1
—
0.6
—
0
9
(3036071) Salmonella sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
5
0.00
0.00
0.0
11.2
—
—
—
0
0
(4146454)
0
7
0.00
0.00
0.0
3.7
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(4027681)
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012565) Volume of 24 hour Urine
0
5
0.00
0.00
0.0
2.4
—
2390.0
—
0
5
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
1.8
—
0
5
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
5
0.00
0.00
0.0
11.2
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(4281824)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
3.3
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
0
9
0.00
0.00
0.0
5.3
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_THYMUS_EXALLC – Malignant neoplasm of thymus, excluding all cancers (controls excluding all cancers)
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).